Søren Nielsen

Professor, Chief Physician, DMSc

Aarhus University Hospital

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Søren Nielsen is a Professor and Chief Physician at Aarhus University Hospital in Denmark. His research focuses on metabolic diseases, specifically examining the intricacies of metabolic dysfunction-associated liver disease, adipose tissue handling, and insulin regulation. Recent publications highlight his work on biomarker-directed diagnostics and the role of glucagon in metabolic functions. Professor Nielsen's contributions to the field are pivotal in understanding and addressing obesity-related metabolic conditions.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (15)

Mogens Johannsen

Aarhus University

DENMARK

Søren Nielsen

Research Interests

Contact this professor

About

Articles (12)

Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer Panels

Similar Insulin Regulation of Splanchnic FFA and VLDL-TG in Men with Nonalcoholic Hepatic Steatosis and Steatohepatitis

Metformin Improves the Prerequisites for FGF21 Signaling in Patients With Type 2 Diabetes

Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms

Glycerol Handling in Paired Visceral and Subcutaneous Adipose Tissues in Women with Normal Weight and Upper-Body Obesity

Insulin regulation of regional lipolysis in upper-body obese and lean humans

Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease

The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease

Localization of aquaglyceroporins in human and murine white adipose tissue

Impaired Glucagon-Mediated Suppression of VLDL-triglyceride Secretion in Individuals with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

Increased lipolysis after infusion of acylated ghrelin: a randomized, double‐blinded placebo‐controlled trial in hypopituitary patients

Collaborators (15)

Mogens Johannsen

Niels Jessen

Esben Søndergaard

Henning Grønbæk

Kristian Løkke Funck

Janne Lebeck

Francesco Maria Iena

Lars Christian Gormsen

Thomas Damgaard Sandahl

Joanna Kalucka

Daniel Miotto Dupont

Marie Winther-Sørensen

Indumathi Kumarathas

Mette Bjerre

Lars Poulsen Tolbod

Make your next move.